| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |